Iranian researchers succeeded in producing PolyPill tablets to prevent myocardial infarction and strokes, and provided the strongest scientific evidence of the effect of this combination drug on significant reduction of cardiovascular diseases and myocardial infarction and strokes in the largest clinical trial of this kind in the world.
The meeting of 100 international scientists, including some researchers from Iran, seeking to understand the causes of cancer with new genetic approaches in collaboration with the major research project "MUTOGRAPHS", was held on July 11 and 12, 2019 at the International Agency for Cancer Research.
The head of the Digestive Diseases Research Institute of Tehran University of Medical Sciences announced the fatty liver the most common liver disease in Iran, and warned against an increase in its prevalence due to the worrying trend of immobility and obesity in the country
Obesity is increasing more rapidly in the world’s rural areas than in cities, according to a new study of global trends in body-mass index (BMI).
Iranian researchers in "Iran in Transition", the article which was published in the April 2019 in International Journal of The Lancet, have broadly examined the health status in Iran over the past centuries up to now.
Although statistics show that Iran has an estimated cases of 15,000 liver failure annually, and more than 5,000 Iranians die every year due to this disease, but Dr. Reza Malekzadeh, the deputy health minister of Iran, says that the country has been able to overcome all shortcomings and difficult obstacles, and by accomplishing more than 6,000 successful liver transplants, it has achieved stunning records in saving the lives of many of the people who die from this disease in 25 years of struggle.
The trend of hypertension with 39% increase in mortality due to it, has become a major threat in Iran during the past 25 years. Meanwhile, Dr Malekzadeh, Director of the Digestive Diseases Research Institute (DDRI) announced that 6.5 million Iranians have hypertension and are unaware of their disease.
With studies of researchers at the Digestive Diseases Research Institute of Tehran University of Medical Sciences, SOVODAK tablet (a combination of Sofosbuvir and Daclatasvir) was developed and the treatment of all genotypes of hepatitis C became definitive and easy
The Head of the Digestive Diseases Research Institute at Tehran University of Medical Sciences reported the annual incidence of more than 10,000 new cases of gastric cancer in the country, as well as the ranking of the 30 provinces for the rate of the deadliest cancer in Iran, as part of the first announcement for the results from the population-based "Gastric Cancer Registry” in Iran
The study of “Polypill” is one of the most important studies conducted at the Digestive Diseases Research Institute (DDRI), which resulted in the production of an effective drug for the prevention of heart attacks and brain strokes
Complete achievement of the goals in the Golestan Cohort Study prompted a new effort, which was the formation of a large, prospective, population-based study with the collaborative participation of medical universities on a population of 200,000 Iranian from all races and ethnicities, named the Persian Cohort Study. The key role of Iranian scientists for the realization of Precision Medicine in the next 20 years is one of its important objectives
The Golestan Cohort Study is the largest cohort study in the Middle East and North Africa, and part of the Gastroesophageal Malignancy in North of Iran (GEMINI) study, is one of the most important medical research projects in Iran.
The “hepatitis C” project is one of the most important research studies conducted by the Digestive Diseases Research Institute (DDRI) which resulted in an important achievement with regards to the definitive treatment of hepatitis C in the country and the survival of hundreds of patients.
The first official report of “Cancer Registry Based on the Entire Iranian Population", was accepted and approved for publication in “Cancer Incidence in Five Continents”, which is recognized as the most credible cancer reference by the WHO
The Islamic Republic of Iran became a permanent member of the INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC)